{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["46(1)"],"submitter":["Ancelin ML"],"pubmed_abstract":["<h4>Background</h4>Cumulative exposure to high glucocorticoid levels is detrimental for the brain and may have particular implications in later life. A feature of late-life depression is increased cortisol secretion. Variants in the CYP11B1 gene, which codes for the enzyme responsible for cortisol synthesis, could influence risk of late-life depression, but this hypothesis has not been examined. We investigated the associations between variants in the CYP11B1 gene and late-life depression, taking into account history of depression and potential sex-specific effects.<h4>Methods</h4>We assessed depression in 1007 community-dwellers aged 65 years or older (60% women) at baseline and over a 14-year follow-up. A clinical level of depression was defined as a score of ≥ 16 on the Centre for Epidemiology Studies Depression scale or a diagnosis of current major depression based on the Mini-International Neuropsychiatric Interview and according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). We examined incident and recurrent depression in participants without or with a history of major depression, respectively. We genotyped 5 single-nucleotide polymorphisms (SNPs) spanning CYP11B1. We used multivariable analyses to adjust for age, body mass index, cardiovascular ischemic pathologies, hypertension, cognitive impairment and anxiety.<h4>Results</h4>In women, rs6471580 and rs7016924 were associated with a 50% lower rate of incident (new-onset) late-life depression, and rs11783855 was associated with a 2.4-fold higher rate of late-life depression. These associations remained after correction for multiple testing, but we found no associations for recurrent depression in women or men.<h4>Limitations</h4>This study focused on the major gene involved in corticosteroid biosynthesis, but other genes may also be implicated in this pathway.<h4>Conclusion</h4>Variants of the CYP11B1 gene appear to be susceptibility factors for late-life depression in a sex-specific manner."],"journal":["Journal of psychiatry & neuroscience : JPN"],"pagination":["E147-E153"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7955840"],"repository":["biostudies-literature"],"pubmed_title":["11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life."],"pmcid":["PMC7955840"],"pubmed_authors":["Ancelin ML","Norton J","Ryan J","Chaudieu I","Ritchie K"],"additional_accession":[]},"is_claimable":false,"name":"11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life.","description":"<h4>Background</h4>Cumulative exposure to high glucocorticoid levels is detrimental for the brain and may have particular implications in later life. A feature of late-life depression is increased cortisol secretion. Variants in the CYP11B1 gene, which codes for the enzyme responsible for cortisol synthesis, could influence risk of late-life depression, but this hypothesis has not been examined. We investigated the associations between variants in the CYP11B1 gene and late-life depression, taking into account history of depression and potential sex-specific effects.<h4>Methods</h4>We assessed depression in 1007 community-dwellers aged 65 years or older (60% women) at baseline and over a 14-year follow-up. A clinical level of depression was defined as a score of ≥ 16 on the Centre for Epidemiology Studies Depression scale or a diagnosis of current major depression based on the Mini-International Neuropsychiatric Interview and according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). We examined incident and recurrent depression in participants without or with a history of major depression, respectively. We genotyped 5 single-nucleotide polymorphisms (SNPs) spanning CYP11B1. We used multivariable analyses to adjust for age, body mass index, cardiovascular ischemic pathologies, hypertension, cognitive impairment and anxiety.<h4>Results</h4>In women, rs6471580 and rs7016924 were associated with a 50% lower rate of incident (new-onset) late-life depression, and rs11783855 was associated with a 2.4-fold higher rate of late-life depression. These associations remained after correction for multiple testing, but we found no associations for recurrent depression in women or men.<h4>Limitations</h4>This study focused on the major gene involved in corticosteroid biosynthesis, but other genes may also be implicated in this pathway.<h4>Conclusion</h4>Variants of the CYP11B1 gene appear to be susceptibility factors for late-life depression in a sex-specific manner.","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jan","modification":"2025-04-25T19:27:01.284Z","creation":"2025-04-06T07:59:17.494Z"},"accession":"S-EPMC7955840","cross_references":{"pubmed":["33245660"],"doi":["10.1503/jpn.190177"]}}